Ezetimibe product-specific bioequivalence guidance
Table of contents
This document provides product-specific guidance on the demonstration of the bioequivalence of ezetimibe tablet 10 mg.
Keywords: Bioequivalence, generics, ezetimibe
Abbreviations:
- BCS Classification: Biopharmaceutics Classification System
- AUC0-t: area under the plasma concentration curve from administration to last observed concentration at time t
- Cmax: maximum plasma concentration
-
List item
Ezetimibe tablet 10 mg product-specific bioequivalence guidance (PDF/126.19 KB)
Adopted
First published: 15/10/2019
Legal effective date: 01/04/2020
EMA/CHMP/802491/2018 -
List item
Overview of comments received on 'Ezetimibe tablet 10 mg product-specific bioequivalence guidance' (EMA/CHMP/802491/2018) (PDF/175.93 KB)
First published: 15/10/2019
EMA/CHMP/401588/2019